177 related articles for article (PubMed ID: 27760342)
41. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
42. Retroviral antibody binding of the MHC class II molecule: a biochemical influence on CD4 T cell differentiation in HIV infection?
Powell PD; Demartini JC
J Theor Biol; 2001 Mar; 209(2):155-60. PubMed ID: 11401457
[TBL] [Abstract][Full Text] [Related]
43. The role of CD8+ T cell soluble factors in human immunodeficiency virus infection.
Copeland KF
Curr Med Chem; 2002 Oct; 9(20):1781-90. PubMed ID: 12369877
[TBL] [Abstract][Full Text] [Related]
44. The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.
Pietra G; Romagnani C; Manzini C; Moretta L; Mingari MC
J Biomed Biotechnol; 2010; 2010():907092. PubMed ID: 20634877
[TBL] [Abstract][Full Text] [Related]
45. CD8+ T-cell-mediated non-cytolytic suppression of human immuno-deficiency viruses.
Vella C; Daniels RS
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):97-113. PubMed ID: 12769788
[TBL] [Abstract][Full Text] [Related]
46. HLA-E: exploiting pathogen-host interactions for vaccine development.
Sharpe HR; Bowyer G; Brackenridge S; Lambe T
Clin Exp Immunol; 2019 May; 196(2):167-177. PubMed ID: 30968409
[TBL] [Abstract][Full Text] [Related]
47. Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?
Sim BC; Lo D; Gascoigne NR
Immunol Today; 1998 Jun; 19(6):276-82. PubMed ID: 9639993
[No Abstract] [Full Text] [Related]
48. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific.
Wilson JD; Ogg GS; Allen RL; Goulder PJ; Kelleher A; Sewell AK; O'Callaghan CA; Rowland-Jones SL; Callan MF; McMichael AJ
J Exp Med; 1998 Aug; 188(4):785-90. PubMed ID: 9705961
[TBL] [Abstract][Full Text] [Related]
49. Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains.
Alves E; Al-Kaabi M; Keane NM; Leary S; Almeida CM; Deshpande P; Currenti J; Chopra A; Smith R; Castley A; Mallal S; Kalams SA; Gaudieri S; John M
PLoS Pathog; 2022 Dec; 18(12):e1010965. PubMed ID: 36525463
[TBL] [Abstract][Full Text] [Related]
50. T-cell repertoire and HIV infection: facts and perspectives.
Cossarizza A
AIDS; 1997 Jul; 11(9):1075-88. PubMed ID: 9233453
[No Abstract] [Full Text] [Related]
51. MHC Class II Tetramer Labeling of Human Primary CD4
Galperin M; Benati D; Claireaux M; Mukhopadhyay M; Chakrabarti LA
Bio Protoc; 2017 Mar; 7(6):e2187. PubMed ID: 34458496
[TBL] [Abstract][Full Text] [Related]
52. Revealing the TCR bias for MHC molecules.
Krovi SH; Gapin L
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2809-11. PubMed ID: 26933216
[No Abstract] [Full Text] [Related]
53. Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.
Penney SJ; Gallant ME; Grant MD
AIDS Res Ther; 2014; 11():30. PubMed ID: 25237383
[TBL] [Abstract][Full Text] [Related]
54. The role of host immune responses in determining the outcome of HIV infection.
Westby M; Manca F; Dalgleish AG
Immunol Today; 1996 Mar; 17(3):120-6. PubMed ID: 8820269
[TBL] [Abstract][Full Text] [Related]
55. HLA-DRB5 promotes immune thrombocytopenia via activating CD8
Ye Q; Ying Q; Chen Y; Liao C; Li A
Open Med (Wars); 2024; 19(1):20240955. PubMed ID: 38799252
[TBL] [Abstract][Full Text] [Related]
56. How mass spectrometric interrogation of MHC class I ligandomes has advanced our understanding of immune responses to viruses.
Ternette N; Adamopoulou E; Purcell AW
Semin Immunol; 2023 Jul; 68():101780. PubMed ID: 37276649
[No Abstract] [Full Text] [Related]
57. Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8
Liu X; Venkataraman G; Lin J; Kiyotani K; Smith S; Montoya M; Nakamura Y; Kline J
Oncoimmunology; 2015 May; 4(5):e1002728. PubMed ID: 26155390
[TBL] [Abstract][Full Text] [Related]
58. New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity.
Yewdell JW; Hickman HD
J Exp Med; 2007 Oct; 204(11):2501-4. PubMed ID: 17954574
[TBL] [Abstract][Full Text] [Related]
59. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.
Park RJ; Wang T; Koundakjian D; Hultquist JF; Lamothe-Molina P; Monel B; Schumann K; Yu H; Krupzcak KM; Garcia-Beltran W; Piechocka-Trocha A; Krogan NJ; Marson A; Sabatini DM; Lander ES; Hacohen N; Walker BD
Nat Genet; 2017 Feb; 49(2):193-203. PubMed ID: 27992415
[TBL] [Abstract][Full Text] [Related]
60. Increased frequencies of CD8
Palmer CD; Romero-Tejeda M; Scully EP; Lockhart A; Seaman MS; Goldenthal A; Piechocka-Trocha A; Walker BD; Chibnik LB; Jost S; Porichis F
J Int AIDS Soc; 2016; 19(1):21136. PubMed ID: 27938646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
